These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10330421)

  • 1. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
    Bucy RP; Hockett RD; Derdeyn CA; Saag MS; Squires K; Sillers M; Mitsuyasu RT; Kilby JM
    J Clin Invest; 1999 May; 103(10):1391-8. PubMed ID: 10330421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals.
    Ehrhard S; Wernli M; Kaufmann G; Pantaleo G; Rizzardi GP; Gudat F; Erb P; Battegay M
    Infection; 2008 Mar; 36(2):120-9. PubMed ID: 18379725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of antiretroviral therapy on programmed death-1 (CD279) expression on T cells in lymph nodes of human immunodeficiency virus-infected individuals.
    Ehrhard S; Wernli M; Dürmüller U; Battegay M; Gudat F; Erb P
    Hum Pathol; 2009 Oct; 40(10):1427-33. PubMed ID: 19439344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
    Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
    AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
    Hengge UR; Borchard C; Esser S; Schröder M; Mirmohammadsadegh A; Goos M
    AIDS; 2002 Jan; 16(2):151-60. PubMed ID: 11807298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.
    Mastroianni CM; Lichtner M; Mengoni F; D'Agostino C; d'Ettorre G; Forcina G; Santopadre P; Massetti AP; Vullo V
    Clin Immunol; 2000 Jun; 95(3):212-7. PubMed ID: 10866128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.
    Kolber MA; Saenz MO; Tanner TJ; Arheart KL; Pahwa S; Liu H
    Clin Immunol; 2008 Mar; 126(3):315-21. PubMed ID: 17997138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of Fas/FasL interactions in HIV-infected patients.
    Badley AD; Dockrell DH; Algeciras A; Ziesmer S; Landay A; Lederman MM; Connick E; Kessler H; Kuritzkes D; Lynch DH; Roche P; Yagita H; Paya CV
    J Clin Invest; 1998 Jul; 102(1):79-87. PubMed ID: 9649560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cd4+ T cells programmed to traffic to lymph nodes account for increases in numbers of cd4+ T cells up to 1 year after the initiation of highly active antiretroviral therapy for human immunodeficiency virus type 1 infection.
    Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
    J Infect Dis; 2001 Jul; 184(1):93-7. PubMed ID: 11398115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses.
    Blazevic V; Jankelevich S; Steinberg SM; Jacobsen F; Yarchoan R; Shearer GM
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):943-8. PubMed ID: 11527808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.